Amedisys, Inc. (NASDAQ:AMED) Shares Purchased by SRS Capital Advisors Inc.

SRS Capital Advisors Inc. boosted its stake in shares of Amedisys, Inc. (NASDAQ:AMED) by 2,298.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,319 shares of the health services provider’s stock after acquiring an additional 1,264 shares during the quarter. SRS Capital Advisors Inc.’s holdings in Amedisys were worth $120,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently modified their holdings of AMED. Westchester Capital Management LLC lifted its holdings in shares of Amedisys by 9.5% during the third quarter. Westchester Capital Management LLC now owns 1,118,802 shares of the health services provider’s stock worth $107,976,000 after purchasing an additional 97,476 shares during the period. Geode Capital Management LLC raised its holdings in Amedisys by 1.3% during the third quarter. Geode Capital Management LLC now owns 567,105 shares of the health services provider’s stock worth $54,746,000 after purchasing an additional 7,071 shares in the last quarter. Pacer Advisors Inc. lifted its position in Amedisys by 11,621.9% in the fourth quarter. Pacer Advisors Inc. now owns 558,197 shares of the health services provider’s stock valued at $50,679,000 after purchasing an additional 553,435 shares during the period. Calamos Advisors LLC boosted its holdings in Amedisys by 22.7% in the 4th quarter. Calamos Advisors LLC now owns 487,444 shares of the health services provider’s stock valued at $44,255,000 after purchasing an additional 90,097 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. increased its position in Amedisys by 2.7% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 346,082 shares of the health services provider’s stock worth $33,400,000 after purchasing an additional 9,004 shares during the period. 94.36% of the stock is currently owned by hedge funds and other institutional investors.

Amedisys Price Performance

Shares of NASDAQ:AMED opened at $92.03 on Thursday. The business’s 50 day simple moving average is $91.69 and its 200-day simple moving average is $93.06. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.19 and a quick ratio of 1.19. The firm has a market capitalization of $3.01 billion, a price-to-earnings ratio of 36.52, a price-to-earnings-growth ratio of 1.78 and a beta of 0.73. Amedisys, Inc. has a 12 month low of $82.15 and a 12 month high of $98.95.

Amedisys (NASDAQ:AMED) last issued its quarterly earnings data on Wednesday, February 26th. The health services provider reported $0.96 EPS for the quarter, missing analysts’ consensus estimates of $1.05 by ($0.09). The business had revenue of $598.05 million during the quarter, compared to analyst estimates of $602.38 million. Amedisys had a net margin of 3.57% and a return on equity of 12.20%. As a group, equities analysts forecast that Amedisys, Inc. will post 4.4 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, Stephens reissued an “equal weight” rating and issued a $101.00 price target on shares of Amedisys in a report on Tuesday. Five research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, Amedisys presently has a consensus rating of “Hold” and a consensus target price of $100.75.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.